- Sales of $5,835.2 million, up 11.6% and up 11.9% when excluding the impact of IFRS 16
- Food same-store sales up 15.6%
- Pharmacy same-store sales up 1.0%
- Net earnings of $263.5 million, up 18.5% and adjusted net earnings(1) of $272.3 million, up 18.2%
- Fully diluted net earnings per share of $1.04, up 20.9% and adjusted fully diluted net earnings per share(1) of $1.08, up 20.0%
- Expenses related to COVID-19 totalling $107 million
- Synergies of $23 million related to the Jean Coutu Group acquisition, $70 million(3) on an annualized basis
Please look at our Press Release (.pdf)
